The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

Share Price Information for Renold (RNO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.10
Bid: 45.20
Ask: 48.00
Change: 1.70 (3.66%)
Spread: 2.80 (6.195%)
Open: 47.00
High: 48.70
Low: 46.00
Prev. Close: 46.40
RNO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Impact of Coronavirus

28 Feb 2020 07:00

RNS Number : 4268E
Renold PLC
28 February 2020
 

Renold plc

("Renold", "the Company" or "the Group")

 

Impact of the Coronavirus

 

28 February 2020

 

Renold, a leading international supplier of industrial chains and related power transmission products, is today providing a trading update reflecting the Board's current assessment of the impact of the Coronavirus outbreak on the Group's performance in the year ending 31 March 2020.

 

As set out in Renold's interim results, announced on 13 November 2019, the Group experienced challenging market conditions in the first half of the year. As anticipated, these challenging conditions have continued into the second half of the year, with the greatest weakness evident in the US and European markets. Despite the negative effect of this subdued demand on revenues, the Group has continued to be effective in mitigating the impact of this through improved operational efficiency and utilising flexibility within cost structures. As a result, the Group had been on track to deliver an adjusted operating profit for the year in line with current market expectations.

 

Notwithstanding this robust performance, the outbreak of the Coronavirus is having a direct impact on certain of the Group's operations. Most notably, this resulted in an extension of the Spring Festival shutdown of our Chinese factory by almost a month. Whilst we are pleased to report that the Chinese factory has reopened, staffing levels are not yet fully recovered due to continuing limitations on the movement of employees. In addition, the extensive disruption and the limited visibility of third party supply chains into both the Chinese factory and our Australasian Chain business, means that there remains uncertainty as to the performance of these business units over the coming months.

 

We are working closely with customers and suppliers to mitigate the impact of these factors but now expect there will be a profit drag across February and March that will not be recoverable before the end of the year. As a result and whilst mindful of the ongoing uncertainty, the Board estimates, based on current information, that the effects described above are likely to reduce adjusted operating profit by approximately £1m in the year to 31 March 2020.

 

Robert Purcell, Chief Executive, said:

 

"While the current year has been a challenging one, with difficult underlying markets, the improvements being delivered within the business are supporting our profitability.

 

"However, the impact of Coronavirus, with the extended shutdown of one of our major factories and continuing uncertainty over Chinese supply chains, has happened close to the end of our financial year and there is no opportunity to recover the operating profit shortfall before March 31st.

 

"Whilst market conditions remain challenging in the near term and a level of uncertainty remains over the longer-term implications of Coronavirus on our business, we are encouraged by the positive impact of our ongoing strategic initiatives."

 

 

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

 

Ian Scapens, Group Finance Director

 

 

 

Peel Hunt LLP

020 7418 8900

Mike Bell

 

Ed Allsopp

 

 

 

Instinctif Partners

020 7457 2020

Mark Garraway

 

Rosie Driscoll

 

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well-deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTTPMMTMTITMIM
Date   Source Headline
15th Apr 20247:00 amRNSTrading update for the year ended 31 March 2024
4th Mar 20241:13 pmRNSHolding(s) in Company
16th Feb 20243:37 pmRNSHolding(s) in Company
5th Feb 20243:49 pmRNSHolding(s) in Company
1st Feb 20249:59 amRNSHolding(s) in Company
18th Jan 20243:41 pmRNSHolding(s) in Company
18th Jan 20243:40 pmRNSHolding(s) in Company
18th Dec 20237:00 amRNSBlock Listing Six Monthly Return
22nd Nov 20237:00 amRNSPreference Stock Dividend
20th Nov 20234:20 pmRNSHolding(s) in Company
16th Nov 20234:53 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSInterim Results
3rd Nov 20237:05 amRNSNotice of Results
5th Sep 20234:15 pmRNSResult of AGM
5th Sep 20237:00 amRNSAGM Trading Update
1st Sep 20237:00 amRNSAcquisition of Davidson Chain PTY
7th Aug 20239:00 amRNS2023 Annual Report and Accounts and 2023 AGM
2nd Aug 20232:21 pmRNSHolding(s) in Company
25th Jul 202312:15 pmRNSGrant of Options
12th Jul 20237:00 amRNSResults for the year ended 31 March 2023
10th Jul 20237:00 amRNSInvestor Presentation
19th Jun 20239:30 amRNSBlock Listing Six Monthly Return
18th May 20237:00 amRNSPreference Stock Dividend
9th May 20237:00 amRNSExtension of banking facilities
3rd May 202311:09 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update and Notice of Results
28th Mar 202312:53 pmRNSHolding(s) in Company
9th Mar 20237:00 amRNSNotice of Capital Markets Day
23rd Feb 202312:09 pmRNSHolding(s) in Company
10th Feb 20232:07 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSTrading Update
25th Jan 202310:00 amRNSHolding(s) in Company
24th Jan 20233:09 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSContract Win
19th Dec 20227:00 amRNSBlock Listing Six Monthly Return
8th Dec 20227:00 amRNSHolding(s) in Company
24th Nov 20225:18 pmRNSPreference Stock Dividend
16th Nov 20227:00 amRNSInterim Results
3rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
12th Oct 20229:12 amRNSHolding(s) in Company
5th Oct 20224:10 pmRNSHolding(s) in Company
20th Sep 202212:34 pmRNSGrant of Options
9th Sep 202211:37 amRNSDirector/PDMR Shareholding
6th Sep 202212:13 pmRNSResult of AGM
6th Sep 20227:00 amRNSAGM Trading Update
4th Aug 20227:30 amRNS2022 Annual Report & Notice of AGM
4th Aug 20227:00 amRNSAcquisition of Industrias YUK S.A.
13th Jul 20227:00 amRNSFinal results for the year ended 31 March 2022
8th Jul 20227:00 amRNSInvestor presentation
17th Jun 20227:00 amRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.